Innovoyce
Boston, US · Founded 2019 · Delaware LLC
Founders & leadership
MD
Michael DavinMr. Davin is the Chief Executive Officer of the Issuer.
TA
Tome AndradeNamed on SEC filing
SZ
Steven ZeitelsNamed on SEC filing
RH
Robert HillmanNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$9.9M disclosed across 1 round · 2022
▶$9.9MraisedOct 2022 · 3 investors · Other Health CareRule 506(b)
▶$9.9MraisedOct 2022 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Tome AndradeDirector
- Steven ZeitelsDirector
- Michael DavinExecutive Officer, Promoter
- Robert HillmanDirector
- Offering amount
- $14.9M
- Amount sold
- $9.9M
- First sale
- Jun 2022
- Incorporated
- Limited Liability Company, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Innovoyce raised?
- Innovoyce has disclosed $9.9M raised across 1 round.
- Where is Innovoyce headquartered?
- Innovoyce is headquartered in Boston, US.